Latest News from AHP

Greg Warren Quoted in AP News Story on New Alzheimer’s Treatment

AHP Partner and Consulting Actuary, Greg Warren, FSA, FCA, MAAA was quoted in the recent AP article: Insurers won’t cover new Alzheimer’s treatment for some customers. "Most insurers will probably cover the drug but heavily restrict its use through things like requiring pre-approval," said Greg Warren, a health actuary and member of the Society of Actuaries. Read the full article at the link below. Read Full Article

David Axene, Tony Pistilli and Erik Axene Slated to Present at 2023 SOA Virtual Health Meeting

AHP Managing Partner David Axene and AHP Chief Medical Officer Erik Axene will present "Use of Health Plan Transparency Data to Radically Transform Provider Contracting" on July 13th. Later in the day David Axene and Consulting Actuary Tony Pistilli will present "Emergency Department Management - A New Potential To Improve Health Care System." View more details about the event and register to attend at the link below. Download the slides for each presentation as [...]

David Axene to Speak at the Virtual Fourth National Medicare Advantage Summit

AHP President and Consulting Actuary, David V. Axene, FSA, CERA, FCA, MAAA, is set to present at the Virtual Fourth National Medicare Advantage Summit. David is presenting "Navigating a Medicare Advantage Termination and Contracting Considerations" on Tuesday April 25, 2023 from 11:50am - 12:40pm. Learn more at the event website. Event Details »

Tony Pistilli Joins SOA Podcast to Discuss 340(b) Drug Program

🎧 Listen as host Jackie Lee and AHP Consulting Actuary Tony Pistilli decode the intricacies of the 340(b) drug program. Discover how the Affordable Care Act has impacted this program and explore the challenges, controversies, and potential solutions to one of the most perplexing aspects of the U.S. healthcare system. Actuaries should keep a close eye on the 340(b) landscape. Don't miss this chance to expand your knowledge and stay ahead of the curve [...]

Tony Pistilli Authors SOA Health Watch Article on 340B Drug Subsidy Program

Check out the latest article "The Run-Away 340B Drug Subsidy Program" by Tony Pistilli in the recent issue of SOA Health Watch. In the article Tony discusses a recent Supreme Court opinion and details some ideas about how 340B reform will better align incentives to optimize patient care by preserving access to medications and the financial stability of care providers. Read the full article below: Read Full Article

Axene Health Partners Announce Internal Promotions

Axene Health Partners recently announced several key promotions during the firm’s annual Christmas Gathering. The firm is pleased to name Pittsburgh, PA office associates Chad Conti, FSA, MAAA and Chris Slaybaugh, FSA, MAAA, to the position of Principal & Consulting Actuary. Additionally, Erik Axene, MD, MA, FACEP has been promoted to Chief Medical Officer, replacing co-founding partner Richard Liliedahl, MD. In honor of Richard’s long tenure and value to the firm, he retains the title of [...]

Go to Top